TY  - CONF 
AU  - POMBO SUAREZ, MANUEL ENRIQUE
AU  - Sanchez-Piedra, C.
AU  - Cuende, E.
AU  - Martin-Domenech, R.
AU  - del Pino, J.
AU  - Fernandez, C. C.
AU  - Manero, J.
AU  - Garcia-Magallon, B.
AU  - Sanchez-Alonso, F.
AU  - Diaz-Gonzalez, F.
AU  - Arteaga, M. J.
AU  - Cea-Calvo, L.
AU  - Gómez-Reino Carnota, Juan Jesús
PY  - 2019
SN  - 0003-4967
UR  - http://hdl.handle.net/20.500.11940/15708
AB  - Background: Survival, or persistence in treatment with a biological drug can be considered an indirect measure of efficacy, safety and tolerability

Objectives: We assessed the probability of persistence (survival) of treatment with golimumab in...
LA  - eng
TI  - Factors associated to persistence of treatment with golimumab in the biobadaser registry, with up to 6 years of follow-up
DO  - 10.1136/annrheumdis-2019-eular.2751
KW  - CHUS
VL  - 78
ER  -